Plain-English translation of NCT05010109 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study follows patients with advanced lung cancer who are receiving radiation therapy combined with chemotherapy and/or immunotherapy. Researchers want to understand how this treatment affects your heart over time by monitoring your heart function, fitness level, and blood markers that indicate heart health.
Radiation therapy for lung cancer can sometimes affect the heart as an unintended side effect. This study aims to detect early signs of heart injury and understand how personalized treatment planning might protect your heart while still treating your cancer effectively.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital or cancer center multiple times over the course of two years. Before, during, and after your radiation therapy, you will complete heart tests including ultrasounds and stress tests, walk a short distance to measure your fitness, and have blood drawn to check for heart markers. Most visits take a few hours, and you'll continue follow-up visits annually for up to 10 years after treatment.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States